Latest KFF Health News Stories
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.
Talk About Déjà Vu: Senators Set To Re-Enact Drug Price Hearing Of 60 Years Ago
Tuesday’s Senate hearing with pharma CEOs will tackle the same issues as the famous Kefauver hearings in 1960.
Today’s Concerns About Drug Prices Echo The Past
Confrontational hearings 60 years ago sparked remarkably similar quotes about drug prices and health care policy.
Podcast: KHN’s ‘What The Health?’ How Safe Are Your Supplements?
Alice Ollstein of Politico, Kimberly Leonard of the Washington Examiner and Anna Edney of Bloomberg News join KHN’s Julie Rovner to discuss the latest national health spending estimates, another FDA crackdown on dietary supplements and lawsuits between insurers and the federal government that could result in a windfall for consumers.
El alto costo del sexo: aseguradoras no pagan por drogas para resolver problemas
Medicare y aseguradoras privadas suelen no pagar los costos de medicamentos que ayudan a superar disfunciones sexuales comunes en adultos mayores.
For 2020 Dem Hopefuls, ‘Medicare-For-All’ Is A Defining Issue, However They Define It
Support for “Medicare-for-all” is becoming a front-runner topic among Democratic presidential candidates. But the phrase is being used to describe any number of policies.
The High Cost Of Sex: Insurers Often Don’t Pay For Drugs To Treat Problems
Medicare and many private insurers view prescribing drugs to improve sexual function as a lifestyle issue that’s not medically necessary to pay for.
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.
Glimpsing The Future At Gargantuan Health Tech Showcase
Innovations to help consumers manage their health were on display at the nation’s largest health technology conference that attracted more than 40,000 health industry professionals to Orlando.
Más allá del Medicare para Todos, estados demócratas impulsan nuevas leyes de salud
Nueva York busca replicar el modelo de San Francisco, que creó un programa de atención médica para todos sus residentes antes del Obamacare.
Podcast: KHN’s ‘What The Health?’ ‘Medicare-For-All’ For Dummies
The “Medicare–for-all” debate is already in full swing, but what does that phrase even mean? Joanne Kenen of Politico, Paige Winfield Cunningham of The Washington Post and Rebecca Adams of CQ Roll Call join KHN’s Julie Rovner for a beginner’s guide to the next big health policy debate. For “extra credit,” the panelists provide their favorite health policy stories of the week, and as a special Valentine’s Day bonus, their favorite #HealthPolicyValentines.
Beyond Beltway’s ‘Medicare-For-All’ Talk, Democrats In States Push New Health Laws
As calls for “Medicare-for-all” grow louder among Democrats in Congress, Democratic governors and mayors have been pushing ahead with urgency to corral medical costs and bring health care to those who remain uninsured.
Can California Beat The Federal Government In Lowering Drug Prices?
Unwilling to wait for federal action, California Gov. Gavin Newsom says he has a plan that could extract discounts from drugmakers and save the state money — one he hopes other states can join.
¿La fuente de la juventud en una píldora? Sí, si eres un ratón
Separar la realidad de la exageración en el campo que estudia la longevidad se ha vuelto más difícil que nunca, más ahora que prestigiosas instituciones incursionan en ese campo.
A ‘Fountain Of Youth’ Pill? Sure, If You’re A Mouse.
The race for the cure to aging sparks hope and hype among top scientists — plus billions of dollars in investment.
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.
Podcast: KHN’s ‘What The Health?’ A ‘Healthy’ State Of The Union
Health was a featured player in President Donald Trump’s 2019 State of the Union address. The president set goals to bring down prescription drug prices, end the HIV epidemic in the U.S. and cure childhood cancer, among other things. Margot Sanger-Katz of The New York Times, Anna Edney of Bloomberg News and Alice Ollstein of Politico join KHN’s Julie Rovner to discuss these issues and, for “extra credit,” provide their favorite health policy stories of the week. Rovner also interviews KHN senior correspondent Phil Galewitz about the current “Bill of the Month” feature.
Trump Administration Salutes Parade Of Generic Drug Approvals, But Hundreds Aren’t For Sale
President Donald Trump and FDA officials have pointed to a surge in generic drug approvals, but a data analysis indicates almost half haven’t reached the market.
Trump Highlights Health Agenda With Vow To Lower ‘Unfair’ Drug Prices
The president laid out a series of goals, including lowering prescription prices, pursuing an end to the HIV epidemic and boosting funding for childhood cancers.
Ideas To Curb Surprise Medical Bills Percolate With Rare Bipartisan Push
The recent declaration by President Donald Trump that taming unexpected medical bills would be a top priority for his administration echoed through the halls of Congress.
